SkinBioTherapeutics plc is a United Kingdom-based life science company focused on skin health. The principal activity of the Company is that of research and development focused on harnessing the microbiome for human health. The Company’s segments include UK, US, and EU. The Company is targeting a number of skin healthcare sectors, which are cosmetic skincare and food supplements to modulate the immune system by harnessing the gut-skin axis. Its platform technology, SkinBiotix, applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin. It targets five specific skin healthcare sectors, such as cosmetics skincare, food supplements for the treatment of skin conditions, medical skin care, infection control in both the home and the hospital environment, and pharmaceuticals for the prescribed treatment of skin conditions. Its first product, AxisBiotix-Ps, is a food supplement to address the symptoms of mild to moderate psoriasis.

• Revenue in GBP (TTM)161.65k
• Net income in GBP-2.88m
• Incorporated2015
• Employees11.00

• Location
  SkinBioTherapeutics PLCThe Core, Newcastle HelixNEWCASTLE UPON TYNE NE4 5TFUnited KingdomGBR
• Phone+44 191 495 7325
• Websitehttps://www.skinbiotherapeutics.com/